Journal of Clinical Microbiology · 1984 · 95 citations · 8 references
MedicineImmunologyInfectious DiseasesHepatologyImmunizationVaccinologyHumoral ImmunityVaccinationViral HepatitisEpidemiological DiagnosisEpidemiological Risk AnalysisHepatitis Virus TestingSerological Screening
To determine the significance of certain serological test results commonly encountered in hepatitis B virus testing, we reviewed serological test data from nine studies of hepatitis B conducted between 1980 and 1982. Three tests, for hepatitis B surface antigen and for antibodies to hepatitis B surface antigen and hepatitis B core antigen (anti-HBs and anti-HBc), were used to measure hepatitis B virus infection risk in various populations. Two results, low levels of anti-HBs alone and low levels of anti-HBc alone, occurred at constant frequencies (2.72 and 0.4%, respectively), regardless of the prevalence of HBV infection in the population. Positivity for low levels of anti-HBs alone persisted for 1 year in less than one-half of those studied; in addition, response to hepatitis B virus vaccine was augmented in only one-third of this group. Positivity for low levels of anti-HBc alone did not persist in any of 11 persons studied. These findings indicate that presently available tests for anti-HBs and anti-HBc at low levels are often nonspecific and should be interpreted with caution.
8
The Prevention of Hepatitis B with Vaccine
Donald P. Francis · Annals of Internal Medicine · 1982 · 444 citations
Saul Krugman, Lacy R. Overby, Isa K. Mushahwar et al. · New England Journal of Medicine · 1979 · 271 citations
Inactivated hepatitis B virus vaccine
John P. Quinn · Clinical Microbiology Newsletter · 1983 · 111 citations
Richard S. Tedder, C.H. Cameron, Ruth Wilson‐Croome et al. · Journal of Medical Virology · 1980 · 70 citations